Literature DB >> 23177353

Metformin: the hidden chronicles of a magic drug.

Khalid Mahmood1, Muhammad Naeem, Nasir Ali Rahimnajjad.   

Abstract

Metformin, a biguanide is well known treatment for type 2 diabetes mellitus that has diverse mechanism of actions. Various studies have elucidated the role of this drug in different pathologies. The well-known United Kingdom Prospective Diabetic Study (UKPDS) has observed its survival benefits in a large cohort of individuals. Data has been conclusive that metformin also has beneficial role in lipid disorders as it improves the markers of metabolic syndrome. Studies have also shown the beneficial roles in antipsychotic induced weight gain as well as HIV lipodystrophy syndrome. Evidence is accumulating that metformin also improves the fertility in females with Polycystic Ovarian Syndrome (PCOS). It also delays aging and is effective in aging related disorders and is equally effective in inflammation related disorders at least in different rodent studies. Metformin's major effect has been shown in various cancers ranging from solid to hematological malignancies. Researchers are working to reveal more benefits of this magic drug but it remains an unexplored territory for the medical community.
Copyright © 2012 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23177353     DOI: 10.1016/j.ejim.2012.10.011

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  23 in total

1.  CGRRF1 as a novel biomarker of tissue response to metformin in the context of obesity.

Authors:  Qian Zhang; Rosemarie Schmandt; Joseph Celestino; Adrienne McCampbell; Melinda S Yates; Diana L Urbauer; Russell R Broaddus; David S Loose; Gregory L Shipley; Karen H Lu
Journal:  Gynecol Oncol       Date:  2014-04       Impact factor: 5.482

Review 2.  Gut microbiota-generated metabolites in animal health and disease.

Authors:  Won-Jae Lee; Koji Hase
Journal:  Nat Chem Biol       Date:  2014-06       Impact factor: 15.040

3.  Presurgical trial of metformin in overweight and obese patients with newly diagnosed breast cancer.

Authors:  Kevin Kalinsky; Katherine D Crew; Susan Refice; Tong Xiao; Antai Wang; Sheldon M Feldman; Bret Taback; Aqeel Ahmad; Serge Cremers; Hanina Hibshoosh; Matthew Maurer; Dawn L Hershman
Journal:  Cancer Invest       Date:  2014-03-07       Impact factor: 2.176

4.  The growing prevalence of type 2 diabetes: increased incidence or improved survival?

Authors:  Nisa M Maruthur
Journal:  Curr Diab Rep       Date:  2013-12       Impact factor: 4.810

Review 5.  The effect of metformin on body mass index and metabolic parameters in non-diabetic HIV-positive patients: a meta-analysis.

Authors:  Narges Nazari Harmooshi; Ahmad Abeshtan; Mehrnoush Zakerkish; Golshan Mirmomeni; Fakher Rahim
Journal:  J Diabetes Metab Disord       Date:  2021-08-12

Review 6.  Insulin resistance, lipodystrophy and cardiometabolic syndrome in HIV/AIDS.

Authors:  Ovidiu Galescu; Amrit Bhangoo; Svetlana Ten
Journal:  Rev Endocr Metab Disord       Date:  2013-06       Impact factor: 6.514

Review 7.  Metformin: A Hopeful Promise in Aging Research.

Authors:  Marta G Novelle; Ahmed Ali; Carlos Diéguez; Michel Bernier; Rafael de Cabo
Journal:  Cold Spring Harb Perspect Med       Date:  2016-03-01       Impact factor: 6.915

Review 8.  Use of noninsulin anti diabetics for prevention and treatment of cancer- narrative review article.

Authors:  Sadaf Raana; Aqeel Javeed
Journal:  Iran J Public Health       Date:  2015-02       Impact factor: 1.429

9.  Incorporation of Sulfonamide Moiety into Biguanide Scaffold Results in Apoptosis Induction and Cell Cycle Arrest in MCF-7 Breast Cancer Cells.

Authors:  Magdalena Markowicz-Piasecka; Karol Sadowski; Johanna Huttunen; Joanna Sikora; Kristiina M Huttunen
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

10.  Saxagliptin and metformin in fixed combination for the treatment of type 2 diabetes in adults.

Authors:  Molly G Minze; Mary S Klein; Brian T Terrell
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2013-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.